21-Dec-12 9:00 AM  CST

Matrixx Initiatives Sends Out an Alert of One Lot of Tainted Zicam Nasal Relief Gel

Matrixx Initiatives is alerting health care providers and the public of one tainted lot of Zicam.  The lot is tainted with Burkholderia Cepacia.  The tainted lot was discovered in a single sample of the particular product taken from the affected lot during a routine inspection of the manufacturing facility. 
Pharmacy Technicians should note the affected lot is: 
            Zicam non drip liquid nasal gel (0.5 oz spray bottle), affected lot 2J23, Expiration 09/2015. 
            NDC Number 62750-005-10
If the contaminated lot is used it is possible that the affected spray could cause upper airway colonization and lead to respiratory infections in patients with compromised immune systems or chronic lung conditions.  The product was distributed nationwide.  Matrixx is in the process of notifying their distributors and retail customers by FedEx letter and via phone.  Pharmacy technicians should advise patients to stop using the affected product and contact Matrixx at 1-877-942-2626 for a full refund.  Adverse events due to the use of the affected Zicam product should be reported to the FDA’s MedWatch Adverse Event Reporting System program by going to http://www.fda.gov/Safety/MedWatch/default.htm
1. Elinor Polack.  “Matrixx Initiatives Issues Nationwide Recall of One Lot of Zicam Extreme Congestion Relief Due To Contamination with Burkholderia Cepacia.” Zicam.com.  Press Release.  18 Dec 2012. 
2. FDA Press Release.  “Zicam Extreme Congestion Relief Nasal Gel:  Recall –Contamination With Burkholderia Cepacia.”  FDA.  Web.  19 Dec 2012. 
3.  Drugs.com Reports.  “Zicam Extreme Congestion Relief Nasal Gel:  Recall – Contamination With Burkholderia.”  Drugs.com.  Web.  19 Dec 2012.     

For additional information on this article, please contact:
Jennifer S. O'Reilly
Source: NPTAnews  

Tendenci™ User Home © 2004 Tendenci™ software by Schipul - "The Web Marketing Company" | www.schipul.com